Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients.

Cusato J, Calcagno A, Marinaro L, Avataneo V, DʹAvolio A, Di Perri G, Bonora S.

Pharmacogenomics J. 2019 Oct 16. doi: 10.1038/s41397-019-0109-x. [Epub ahead of print]

PMID:
31619748
2.

Predictors of blood pressure control in patients with resistant hypertension after intensive management in two expert centres: the Brussels-Torino experience.

Pappaccogli M, Di Monaco S, Coralie G, Petit G, Eula E, Ritscher S, Lengelé JP, Fanelli E, Severino F, Renkin J, Avataneo V, Wallemacq P, Toennes SW, de Timary P, Rabbia F, Persu A.

Blood Press. 2019 Oct;28(5):336-344. doi: 10.1080/08037051.2019.1633908. Epub 2019 Jul 1.

PMID:
31257937
3.

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients.

Allegra S, Cusato J, De Francia S, Longo F, Pirro E, Massano D, Avataneo V, De Nicolò A, Piga A, D'Avolio A.

Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.

PMID:
30651574
4.

LC-MS application for therapeutic drug monitoring in alternative matrices.

Avataneo V, D'Avolio A, Cusato J, Cantù M, De Nicolò A.

J Pharm Biomed Anal. 2019 Mar 20;166:40-51. doi: 10.1016/j.jpba.2018.12.040. Epub 2018 Dec 29. Review.

PMID:
30609393
5.

Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients.

Allegra S, Cusato J, De Francia S, Longo F, Pirro E, Massano D, Avataneo V, De Nicolò A, Piga A, D'Avolio A.

Pharmacogenet Genomics. 2018 Sep;28(9):199-206. doi: 10.1097/FPC.0000000000000348.

PMID:
30179981
6.

A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples.

Avataneo V, De Nicolò A, Rabbia F, Sciandra M, Tosello F, Cusato J, Perlo E, Fatiguso G, Allegra S, Favata F, Mulatero P, Veglio F, Di Perri G, D'Avolio A.

J Pharmacol Toxicol Methods. 2018 Nov - Dec;94(Pt 2):29-35. doi: 10.1016/j.vascn.2018.08.003. Epub 2018 Aug 28.

PMID:
30165207
7.

Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.

Avataneo V, De Nicolò A, Rabbia F, Perlo E, Burrello J, Berra E, Pappaccogli M, Cusato J, D'Avolio A, Di Perri G, Veglio F.

Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15.

8.

Pharmacogenetic of voriconazole antifungal agent in pediatric patients.

Allegra S, Fatiguso G, Francia S, Pirro E, Carcieri C, Cusato J, Nicolò A, Avataneo V, Perri GD, D'Avolio A.

Pharmacogenomics. 2018 Jul 1;19(11):913-925. doi: 10.2217/pgs-2017-0173. Epub 2018 Jun 19.

PMID:
29914286
9.

Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations.

Allegra S, Cardellino CS, Fatiguso G, Cusato J, De Nicolò A, Avataneo V, Bonora S, D'Avolio A, Di Perri G, Calcagno A.

J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.

PMID:
29873816
10.

Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study.

Cusato J, De Nicolò A, Boglione L, Favata F, Ariaudo A, Mornese Pinna S, Carcieri C, Guido F, Avataneo V, Cariti G, Di Perri G, D'Avolio A.

J Antimicrob Chemother. 2018 Jun 1;73(6):1659-1664. doi: 10.1093/jac/dky053.

PMID:
29509884
11.

Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients.

Cusato J, De Nicolò A, Boglione L, Favata F, Ariaudo A, Mornese Pinna S, Carcieri C, Guido F, Avataneo V, Cariti G, Di Perri G, D'Avolio A.

Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13.

PMID:
29452294
12.

Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs.

Cusato J, Boglione L, De Nicolò A, Favata F, Ariaudo A, Mornese Pinna S, Guido F, Avataneo V, Cantù M, Carcieri C, Cariti G, Di Perri G, D'Avolio A.

Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22.

PMID:
29356898
13.

Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study.

Cusato J, De Nicolò A, Boglione L, Favata F, Ariaudo A, Mornese Pinna S, Guido F, Avataneo V, Carcieri C, Cariti G, Di Perri G, D'Avolio A.

J Antimicrob Chemother. 2017 Oct 1;72(10):2846-2849. doi: 10.1093/jac/dkx237.

PMID:
29091211
14.

Cannabinoids concentration variability in cannabis olive oil galenic preparations.

Carcieri C, Tomasello C, Simiele M, De Nicolò A, Avataneo V, Canzoneri L, Cusato J, Di Perri G, D'Avolio A.

J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.

PMID:
29057480
15.

A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples.

Fatiguso G, Favata F, Zedda I, De Nicolò A, Cusato J, Avataneo V, Di Perri G, D'Avolio A.

J Pharm Biomed Anal. 2017 Oct 25;145:718-724. doi: 10.1016/j.jpba.2017.07.040. Epub 2017 Aug 5.

PMID:
28806568
16.

UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples.

De Nicolò A, Avataneo V, Rabbia F, Sciandra M, Tosello F, Cusato J, Perlo E, Mulatero P, Veglio F, Di Perri G, D'Avolio A.

J Pharm Biomed Anal. 2017 Aug 5;142:279-285. doi: 10.1016/j.jpba.2017.05.018. Epub 2017 May 13.

PMID:
28538203
17.

UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients.

De Nicolò A, Avataneo V, Rabbia F, Bonifacio G, Cusato J, Tomasello C, Perlo E, Mulatero P, Veglio F, Di Perri G, D'Avolio A.

J Pharm Biomed Anal. 2016 Sep 10;129:535-541. doi: 10.1016/j.jpba.2016.07.049. Epub 2016 Aug 1.

PMID:
27497654
18.

Striatal astrocytes produce neuroblasts in an excitotoxic model of Huntington's disease.

Nato G, Caramello A, Trova S, Avataneo V, Rolando C, Taylor V, Buffo A, Peretto P, Luzzati F.

Development. 2015 Mar 1;142(5):840-5. doi: 10.1242/dev.116657. Epub 2015 Feb 5.

Supplemental Content

Loading ...
Support Center